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Lysosome is the principal organelle for the ultimate degradation of cellular 32 
macromolecules, which are delivered through endocytosis, phagocytosis and autophagy. 33 
The lysosomal functions have been found to be impaired by fatty foods and aging, and 34 
more importantly, the lysosomal dysfunction in macrophages has been reported as a risk 35 
of atherosclerosis development. In this study, we searched for dietary polyphenols which 36 
possess the activity for enhancing the lysosomal degradation in J774.1, a murine 37 
macrophage-like cell line. Screening test utilizing DQ-BSA digestion identified 38 
isorhamnetin (3’-O-methylquercetin) as an active compound. Interestingly, structural 39 
comparison to inactive flavonols revealed that the chemical structure of the B-ring moiety 40 
in isorhamnetin is the primary determinant of its lysosome-enhancing activity. 41 
Unexpectedly isorhamnetin failed to inhibit mTORC1-TFEB signaling, a master 42 
regulator of lysosomal biogenesis and function. Our data suggested that the other 43 
molecular mechanism might be critical for the regulation of lysosomes in macrophages. 44 
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The lysosome is an acidic organelle which plays the pivotal role in the 49 
degradation of extracellular or intracellular macromolecules. More than 60 kinds of acid 50 
hydrolases are identified to function inside lysosomes, which enables to digest a broad 51 
range of substrates into catabolites such as amino acids, fatty acids and monosaccharides. 52 
Also, it is well known that various kinds of characteristic proteins, including structural 53 
proteins like lysosomal-associated membrane protein 1 (LAMP1) family, vacuolar-type 54 
proton ATPase (V-ATPase) complexes for the lysosomal acidification, the lysosomal 55 
proteases (cathepsins), and soluble N-ethylmaleimide-sensitive-factor attachment protein 56 
receptor (SNAREs) that mediate its fusion with other organelles, are essential for the 57 
lysosomal functions. (1, 2) 58 
Many reports have demonstrated that the lysosomal dysfunction is associated 59 
with the onsets of several diseases. Loss-of-function mutations in lysosomal hydrolases 60 
or lysosomal membrane proteins such as -galactosidase and mucolipin-1 have been 61 
shown to lead to the intracellular accumulation of aberrant lysosomes, which causes 62 
Fabry disease and mucolipidosis type IV, respectively (3, 4, 5). Importantly, beside these 63 
genetic mutation or deletion, recent reports suggested the possibility that aging and 64 
chronic high-fat diet might also attenuate lysosomal proteolysis activity (6, 7, 8).  65 
Macrophages are professional phagocytic cells which engulf and digest 66 
apoptotic cells and exogenous bacteria for the immune response. It is obvious that 67 
adequate lysosomal activity is indispensable for macrophages to accomplish the 68 
phagocytosis process. Indeed, it has been reported that the genetic deletion of 69 
glucocerebrosidase, a lysosomal glycoside hydrolase, impaired endocytosis in 70 
macrophages and increased susceptibility to tuberculosis (9). Furthermore, Sergin et al. 71 
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found that augmentation of lysosomal activity in macrophages by overexpressing 72 
transcriptional factor EB (TFEB), a master regulator of lysosomal biogenesis and function, 73 
suppressed the development of aortic root atherosclerosis in apolipoprotein E (ApoE) -74 
knockout mice (10). These observations suggested that the maintenance of lysosomal 75 
function in macrophages might be a potential therapeutic target for these diseases. 76 
Polyphenols are plant-derived ingredients with multiple phenol structural units, 77 
and we intake them from vegetables and fruits in our daily diet. They are classified into 78 
flavonoids, lignans, stilbenes and curcuminoids according to the differences in chemical 79 
structures. In particular, flavonoids have been well-studied about their functionality and 80 
further classified into nine chemical groups (flavones, flavonols, isoflavones, flavans, 81 
flavanols, flavanones, flavanonols, chalcones, and anthocyanidins) (11). Although it is 82 
noted that several flavonoids, such as quercetin, kaempferol and epigallocatechin-3-83 
gallate (EGCG), have been reported to enhance autophagy (12, 13, 14) in some in vitro models, 84 
few studies have focused on the lysosomal proteolysis activity in macrophages. 85 
Recent studies have identified TFEB as one of the most critical regulators of 86 
lysosomal numbers and activities. Under the nutrients-rich condition, TFEB is negatively 87 
regulated by mechanistic target of rapamycin complex 1 (mTORC1) in the cytoplasm (15), 88 
whereas amino acids depletion immediately induce TFEB transactivation through 89 
mTORC1 inactivation, followed by the upregulation of global gene expressions involved 90 
in lysosomal biogenesis and function (16). Consistent with these studies, Moskot et al. 91 
showed that the treatment of genistein (4′, 5, 7-trihydroxyisoflavone) upregulated some 92 
lysosomal gene expressions such as cathepsin F (Ctsf) and mucolipin 1 (Mcoln1), through 93 
TFEB transactivation in Hela cells (17). 94 
In this study, we screened for polyphenol compounds which enhance lysosomal 95 
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proteolysis in a macrophage-like cell line, J774.1. We then found that the treatment of 96 
isorhamnetin (3’-O-methylquercetin) significantly activated the lysosomal proteolysis. 97 
Additionally, it was also interesting that the chemical structure of B-ring in isorhamnetin 98 
were significant for its bioactivity. The potential molecular mechanism of isorhamnetin 99 
activity was investigated, which was suggested to be independent on mTORC1-TFEB 100 
signaling. 101 
 102 
Materials and Methods 103 
Reagents 104 
Dulbecco's modified eagle medium (DMEM, 4.5 g/L glucose, liquid; 08458-16), 105 
penicillin-streptomycin mixed solution (Stabilized; 09367-34), protease inhibitor cocktail, 106 
phosphatase inhibitor cocktail (04080-11), and bovine serum albumin (BSA; 01281-26) 107 
were obtained from Nacalai Tesque Inc. (Kyoto, Japan). Pronase protease (Streptomyces 108 
griseus; 9036-06-0) was from Sigma-Aldrich (St. Louis, MO, USA). HRP-conjugated 109 
antibodies to mouse or rabbit IgG (AP124P or AP124P) were purchased from Millipore 110 
Inc. (Billerica, MA, USA). Rabbit polyclonal antibody to Phospho-4E-BP1 (Thr37/46) 111 
(236B4; #7547) was from Cell Signaling Technology Inc. (Beverly, MA, USA). Mouse 112 
polyclonal antibody to β-Actin (C4; sc-4778) was purchased from Santa Cruz 113 
Biotechnology Inc. (Dallas, TX, USA). DQ™ Green BSA (D12050) was obtained from 114 
Invitrogen (Carlsbad, CA, USA). Fetal bovine serum (FBS; 10270-106) and 115 
FluoroBrite™ DMEM (A1896701) was from Thermo Scientific Inc. (Waltham, MA, 116 
USA). Xfect™ Transfection Reagent (631317) was purchased from Takara Inc. (Kyoto, 117 
Japan). Hoechst 33342 (CDX-B0030) was obtained from Chemodex Inc. (St. Gallen, 118 
Switzerland). Methanol (25183-70) and acetonitrile (01031-70) were from Kanto 119 
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Chemical Co. Inc. (Tokyo, Japan). Actinomycin D (014-21261) was purchased from 120 
FUJIFILM Wako Pure Chemical Co. (Tokyo, Japan). Bafilomycin A1 (14005) and Torin1 121 
(10997) were obtained from Cayman Chemical Co. (Ann Arbor, MI, USA). Polyphenol 122 
compounds are obtained by the way shown below. 3'-O-Me-luteolin (1104S), 6-O-Me-123 
luteolin (520-11-6), 7,4'-dihydroxyflavone (1259), datiscetin (1141S), eriodictyol (0056), 124 
flavonol (1026), homoeriodictyol (1118S), isoramnetin-3G (1228), isorhamnetin (1120S), 125 
kaempferol-3G (1243G), luteolin-7G (1126S), Q3G (0074), quercetagetin (1030), 126 
rhamnetin (1136S), tamarixetin (1140S) and tricetin (1335S) were from Extrasynthese 127 
(Genay, France). 2,2',4'-trihydroxychalcone (T502), 4,2',5'-trihydroxychalcone (22-314) 128 
and gossypetin (G500) were from INDOFINE Chemical Company Inc. (NJ, USA). 129 
Flavone (16012-31), morin (23416-31) and pyrogallol (29703-52) were from Nacalai 130 
Tesque Inc. (Kyoto, Japan). EGCG (E4268), hyperoside (00180585-25MG) and 131 
phloroglucinol (79330-25G) were from Sigma-Aldrich (MO, USA). 1,2,4-132 
trihydroxybenzene, daidzin, piceid, rutin and tangeretin were from Tokyo Chemical 133 
Industry Co., Ltd. (Tokyo, Japan). 3,4-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 134 
cyanidin, hesperetin and sudachitin were from FUJIFILM Wako Pure Chemical 135 
Corporation (Osaka, Japan). Other polyphenols were from natural compound libraries 136 
(S990043-NAT1/NAT2) purchased from Sigma-Aldrich (MO, USA). 137 
 138 
Cell culture 139 
J774.1, mouse macrophage-like cell line, was obtained from American Type 140 
Culture Collection. RAW264.7, mouse macrophage-like cell line, was kindly provided by 141 
Dr. T. Nikawa (Tokushima University). They were cultured in DMEM with 10% FBS, 142 





DQ-BSA degradation assay 146 
DQTM Green BSA (DQ-BSA) was dissolved in phosphate-buffered saline (PBS) 147 
to make 1 mg/mL solution. Polyphenol compounds were dissolved in dimethyl sulfoxide 148 
(DMSO) to make 10 mM solution. For measurement of degradation products of DQ-BSA 149 
in cells, cells were seeded on black-wall clear-bottom 96-well plates (655090; Greiner 150 
Bio-One, Frickenhausen, Germany) (6.0×104 cells/well) and pre-cultured overnight. They 151 
were treated each polyphenol for indicated time with a final DMSO concentration of 0.1%, 152 
then added the DQ-BSA solution to a final concentration of 10 µg/mL. After incubation 153 
for 1 h, to quantify fluorescence intensity from digested DQ-BSA, cells were imaged by 154 
using Operetta high-content imaging system (PerkinElmer, MA, USA) at 40x 155 
magnification at following settings: (λ ex: 460-490 nm, λ em: 500-550 nm). Cell shapes 156 
were individually recognized by digital phase contrast and fluorescent intensity in each 157 
cell was quantified using dedicated imaging software (Harmony 4.5; PerkinElmer, MA, 158 
USA). In the case of using a fluorescent scanner, cells were seeded on 48-well plates 159 
(1.2×105 cells/well). After treatment with polyphenols and subsequent DQ-BSA, cells 160 
were scanned by Typhoon FLA9500 (GE Healthcare, Buckinghamshire, UK) at following 161 
settings: (λ ex: 473 nm, λ em: 520-540 nm). To correct differences in cell number during 162 
each treatment, cellular proteins were quantified using Protein Assay Bicinchoninic acid 163 
Kit (06385-00; Nacalai Tesque, Kyoto, Japan) to yield the ratio of fluorescence intensity/ 164 
cellular protein amounts. 165 
For quantification of degradation products of DQ-BSA in conditioned medium, 166 
cells seeded on 12-well plates (6.0×106 cells/well) were treated with isorhamnetin (10 167 
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µM) or Torin1 (1 µM) for 24 h, then incubated with DQ-BSA (final 10 µg/mL) for 4 h. 168 
50 µL of conditioned media was added into 450 µL of ice-cold methanol, then incubated 169 
at -20°C for 30 min for protein precipitation. After centrifugation (20,600 g, 4°C, 15 min), 170 
10 µL of the supernatant was injected into a high-performance liquid chromatography 171 
(HPLC) column (0017201; TSKgel ODS-80Ts, 4.6 mm×150 mm, Tosoh Bioscience, 172 
Tokyo, Japan). The solvent system consisted of 0.1% trifluoroacetic acid (TFA) in 30% 173 
acetonitrile and 70% H2O, and flow rate was 0.8 mL/min. Fluorescence detection was 174 
performed at following settings (λ ex: 505 nm, λ em: 515 nm). To prepare in vitro 175 
degradation products of DQ-BSA, 10 µg of DQ-BSA was incubated with 30 µg of pronase 176 
in 100 µL of 50 mM Tris-HCl buffer at 37°C for overnight. The sample was added into 177 
800 µL of ice-cold methanol, and incubated at -20°C for 30 min. After centrifugation 178 
(20,600 g, 4°C, 15 min), 10 µL of the supernatant was injected into an HPLC column and 179 
analyzed in the way described above. 180 
 181 
Fluorostaining of intracellular acidic compartment using Lysotracker 182 
Cells were seeded into black-wall clear-bottom 96-well plates. After treatment 183 
with isorhamnetin (10 µM) or Torin1, mTOR inhibitor, (1 µM) for 24 h, cells were 184 
incubated with Lysotracker® Green DND-26 (L7526; Thermo Scientific, MA, USA) 185 
(final 0.5 µM) for 30 min. Following washing with FluoroBrite™ DMEM three times, 186 
green fluorescence from Lysotracker inside cells was imaged by using Operetta high-187 
content imaging system at 40x magnification at following settings: (λ ex: 460-490 nm, λ 188 
em: 500-550 nm). Fluorescence intensity of each cell was quantified in the way described 189 




Fluoroimaging of lysosomal cathepsin B activity 192 
Magic Red® (937; Cosmo Bio, Tokyo, Japan) was dissolved into DMSO/water 193 
(1/1). Then, cells were seeded into black-wall clear-bottom 96-well plates. After treatment 194 
with isorhamnetin (10 µM) or Torin1 (1 µM) for 24 h, cells were incubated with Magic 195 
Red solution (2 µL/well) for 10 min. Following washing with FluoroBrite™ DMEM 196 
twice, cells were imaged by using Operetta high-content imaging system at 40x 197 
magnification at following settings: (λ ex: 530-560 nm, λ em: 570-650 nm). Red 198 
fluorescence intensity from digested Magic Red reagent inside each cell was quantified 199 
in the way described above. 200 
 201 
Quantitative analyses of flavonols in cells 202 
Cells were seeded on 12-well plates, and treated with each flavonol (10 µM) for 203 
1 or 24 h. After washing cells with PBS five times, they were lysed with 300 µL of 1% 204 
acetic acid in methanol, containing flavone (10 nM) as an internal standard. Lysates were 205 
sonicated for 1 min and centrifuged at 20,600 g for 10 min for protein precipitation, and 206 
the supernatants were collected for liquid chromatography tandem mass spectrometry 207 
(LC-MS/MS) analyses. Quantitative analyses were performed using HPLC system 208 
interfaced to API3200 instrument (SCIEX, MA, USA) working with triple quadrupole 209 
analyser in multiple reaction monitoring (MRM) mode. 5 µL of each sample solution was 210 
injected into an HPLC column (CD024F; CD-C18 MF, 2 mm×100 mm, Imtakt, Kyoto, 211 
Japan). The solvent system consisted of 0.1% FA in H2O (solvent A) and 0.1% FA in 212 
acetonitrile (solvent B). The gradient program was as follows: 0-2 min, 25% B; 2-10 min, 213 
linear gradient to 100% B; 10-15 min, 100% B hold; flow rate, 0.2 mL/min. The ESI-MS 214 
and MS/MS analysis were performed in negative mode. The ESI-MS source parameters 215 
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were optimized as follows: curtain gas, 10 psi; ion source gas 1, 30 psi; ion source gas 2, 216 
80 psi; temperature, 700°C; and ion spray voltage, -4500 V, collision activated 217 
dissociation, 5 psi. The MS/MS transitions of m/z 314.932 → 300.000, 314.932 → 218 
300.000, 284.845 → 92.900, 300.849 → 151.100, and 316.780 → 151.100 were for 219 
isorhamnetin, tamarixetin, kaempferol, quercetin and myricetin respectively. 220 
 221 
Microscopic observation of intracellular GFP-tagged TFEB 222 
Cells seeded on 12-well plates were transfected with pEGFP-N1-TFEB plasmid 223 
(38119; Addgene Inc., MA, USA) using Xfect™ Transfection Reagent. After recovery 224 
for 24 h, cells were reseeded into black-wall clear-bottom 96-well plates, and treated with 225 
isorhamnetin (10 µM) or Torin1 (1 µM) for 1 h. Hoechst 33342 was added into media 226 
(final 1 µg/mL) for staining nuclei, then cells were washed with FluoroBrite™ DMEM 227 
twice. Fluorescent image was captured by using Operetta high-content imaging system at 228 
40x magnification at following settings: (GFP; λ ex: 460-490 nm, λ em: 500-550 nm, 229 
Hoechst 33342; λ ex: 355-385 nm, λ em: 430-500 nm). 230 
 231 
Real-time reverse-transcription polymerase chain reaction 232 
Total RNA, prepared using Sepasol®-RNA I Super G (09379-55; Nacalai Tesque, 233 
Kyoto, Japan), was reverse transcribed by ReverTra Ace® qPCR RT Master Mix with 234 
gDNA Remover (FSQ-301; Toyobo, Osaka, Japan). Then, cDNA was used as template 235 
for real-time quantitative polymerase chain reaction (RT-qPCR) analysis with 236 
THUNDERBIRD® SYBR qPCR Mix (QPS-201; Toyobo, Osaka, Japan) using 237 
LightCycler® Nano System (Roche Diagnostics K.K., Tokyo, Japan). The relative 238 
expression of each mRNA was calculated according to the 2-ΔΔCt method. GAPDH was 239 
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considered as internal control gene. The used primer sequences were as follows: ATPase 240 
H+ transporting V0 subunit d2 (Atp6v0d2), forward 5'- AAGCCTTTGTTTGACGCTGT 241 
-3' and reverse 5'- GCCAGCACATTCATCTGTACC -3'; cathepsin D (Ctsd), forward 5'- 242 
CTGAGTGGCTTCATGGGAAT -3' and reverse 5'- CCTGACAGTGGAGAAGGAGC -243 
3'; glyceraldehyde-3-phosphate dehydrogenase (Gapdh), forward 5'- 244 
GTGAAGGTCGGAGTCAACG -3' and reverse 5'- TGAGGTCAATGAAGGGGTC -3'; 245 
lysosomal-associated membrane protein 2a (Lamp2a), forward 5'- 246 
GCAGTGCAGATGAAGACAAC -3' and reverse 5'- AGTATGATGGCGCTTGAGAC -247 
3'.  248 
 249 
Western blotting 250 
Cells were washed with PBS, and lysed in a radio-immunoprecipitation assay 251 
buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.25% deoxycholic acid, 1% NP-40, 252 
0.1% sodium dodecyl sulfate (SDS), 1 mM ethylenediaminetetraacetic acid] 253 
supplemented with both protease and phosphatase inhibitor cocktails. The protein 254 
concentrations in cell lysates were measured by BCA assay. Proteins were separated on a 255 
10% SDS/polyacrylamide gel, then transferred to Immobilon-P PVDF membranes 256 
(IPVH00010; Millipore, MA, USA). The membrane was blocked with EzBlock Chemi 257 
(2332615; Atto Corp., Tokyo, Japan) at room temperature for 30 min, then probed with a 258 
primary antibody (1:1000) in Tris-buffered saline with 0.05% Tween 20 (TTBS) 259 
containing 5% BSA at 4 °C overnight. After washing with TTBS, they were incubated in 260 
solution containing secondary antibody conjugated with horseradish peroxidase (1:2000) 261 
at room temperature for 75 min. After washing, chemiluminescent detection was 262 
performed using Chemi-Lumi One or Chemi-Lumi One Super (07880, 02230; Nacalai 263 
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Tesque, Kyoto, Japan) and visualized by Ex-Capture MG (Atto Corp., Tokyo, Japan). 264 
 265 
Statistical analysis 266 
All data were expressed as means ± SEM. Statistical analysis were performed using t-test 267 
or one-way analysis of variance (ANOVA). When ANOVA indicated a significant 268 
difference among groups, these groups were compared by Dunnett’s or Tukey’s test. All 269 
statistical analyses were performed using Prism 5 (GraphPad Software, CA). The 270 
threshold for statistical significance was set at p < 0.05. 271 
 272 
Results 273 
Screening of dietary polyphenols which enhance lysosomal proteolysis in J774.1 cells 274 
First, we attempted to establish a cell-based system to measure the activity of 275 
lysosomal proteolysis. We used DQ-BSA, BSA protein chemically modified with a kind 276 
of boron dipyrromethene (BODIPY) dye, for the assay system. This reagent is designed 277 
to be internalized into the cytoplasm to be degraded in lysosomes eventually, which is 278 
accompanied by the robust increase of fluorescence emission. DQ-BSA treatment to 279 
J774.1 mouse macrophage-like cells immediately increased the intracellular green 280 
fluorescence [Fig. 1a], suggesting its proteolytic degradation. To confirm whether the 281 
fluorescence intensity is indeed available as a quantitative indicator of lysosomal activity, 282 
we quantified the cellular fluorescence intensity after pre-treatment with Torin1, an 283 
mTOR inhibitor, which had been reported to facilitate DQ-BSA degradation in several 284 
cultured cell lines, and bafilomycin A1 (BAF), a chemical inhibitor of lysosomal 285 
acidification (18, 19) [Fig. 1a and b]. Expectedly, inhibition of lysosomal activity by BAF 286 
treatment resulted in the remarkable reduction of DQ-BSA-derived fluorescence, whereas 287 
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Torin1 significantly increased the intensity similarly to the previous reports. 288 
Then, 56 kinds of dietary polyphenols, including flavonol, catechin, flavanone, 289 
anthocyanidin, flavanol, flavone, stilbene, isoflavone and chalcone, were treated to J774.1 290 
cells respectively for the assessment of their effects on the lysosomal proteolysis (n=1). 291 
This screening test was performed at 10 µM concentration for all compounds because few 292 
of them showed cytotoxicity at up to this concentration upon 24 h treatment [data not 293 
shown]. We found that the treatment of a few flavonol compounds, including 294 
isorhamnetin, tended to enhance DQ-BSA degradation [Fig. 1c]. To verify the inducing 295 
activity of isorhamnetin on this assay system, we further performed DQ-BSA assay under 296 
several different experimental conditions, which revealed that treatment of isorhamnetin 297 
at relatively high concentrations (10 or 20 µM) significantly enhanced DQ-BSA 298 
degradation [Fig. 1d]. Additionally, it was found that its treatment for a shorter time (1-299 
12 h) was not fully effective to enhance DQ-BSA digestion [Fig. 1e]. These results 300 
demonstrated that 24 h treatment of isorhamnetin, a kind of dietary flavonols, promote 301 
lysosomal proteolysis in J774.1.  302 
 303 
Isorhamnetin activated lysosomal functions in J774.1 cells. 304 
Given the possibility that isorhamnetin may enhance DQ-BSA intake through 305 
endocytosis as well as its lysosomal proteolysis, we attempted to assess the lysosomal 306 
properties by using other methodologies. Staining cells with lysotracker revealed that the 307 
area of acidic compartments per cell were significantly increased by isorhamnetin 308 
treatment [Fig. 2a and b], suggesting increased number of lysosomes. Regarding the 309 
proteolytic activity of lysosomes, the enzymatic activity of cathepsin B, one of lysosomal 310 
cysteine proteases, was evaluated by using a fluorescent substrate, Magic Red, showing 311 
14 
 
its significant activation by isorhamnetin treatment [Fig. 2c and d]. 312 
Interestingly, we also found that conditioned media of J774.1 cells treated with 313 
DQ-BSA emitted the remarkable green fluorescence, implying that the degradation 314 
products of DQ-BSA might be partly secreted into the media. To validate this hypothesis, 315 
we established another analytical methodology using HPLC-Fluorescence system which 316 
is capable to detect the final proteolytic products of DQ-BSA specifically. Proteolytic 317 
product of DQ-BSA, yielded by the in vitro incubation with pronase, was successfully 318 
detected as a single peak by the HPLC-Fluorescence analysis [Fig. 2e]. Expectedly, 319 
conditioned media of cells treated with DQ-BSA was found to contained fluorescent 320 
molecules with an almost identical retention time [Fig. 2f], and it was also notable that 321 
isorhamnetin treatment increased its extracellular secretion [Fig. 2g]. Furthermore, we 322 
confirmed that the enhancement of DQ-BSA degradation by isorhamnetin was observed 323 
in other mouse macrophage-like cell line, RAW264.7 [Fig. 2h]. These results confirmed 324 
that isorhamnetin treatment on murine macrophage-like cells led to the lysosomal 325 
activation. 326 
 327 
3’-Methoxy group in B-ring moiety is critical for isorhamnetin activity 328 
Based on the screening test shown in Figure 1c, isorhamnetin, a flavonol 329 
compound possessing mono-methoxylated B-ring, seemed to be the most effective among 330 
56 candidates. Focusing on its characteristic structure of B-ring, the activities of 4 other 331 
flavonols with slightly differed B-ring (tamarixetin, kaempferol, quercetin and myricetin; 332 
Fig. 3a) were re-evaluated in triplicate by DQ-BSA assay. Intriguingly, these flavonol 333 
compounds, whose B-ring moieties were structurally varied, were shown to be inactive 334 
regarding to lysosomal proteolysis [Fig. 3b]. This result indicated the biological 335 
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significance of the chemical structure, 3’-methoxy-4’-hydroxy groups, on B-ring moiety 336 
in isorhamnetin. 337 
Since the molecular polarities and stabilities of these 5 flavonols were speculated 338 
to be slightly differed, we attempted to quantify the amount of each compound 339 
accumulated in the cells after 1 or 24 h treatment. LC-MS/MS analysis of cell lysates 340 
revealed that 4 kinds of flavonols other than myricetin were interacted with cells after 1 341 
h treatment. After 24 h treatment, quercetin was markedly reduced, whereas compounds 342 
with relatively hydrophobic B ring moiety, isorhamnetin, tamarixetin, and kaempferol, 343 
kept interacted with cells. [Fig. 3c and d]. It was noted that tamarixetin and kaempferol 344 
seemed to possess higher affinities for cells in spite of their less activities. It was also 345 
interesting that small amounts of isorhamnetin (0.07±0.006 nmol/mg protein; 1 h, 346 
0.01±0.003 nmol/mg protein; 24 h) were detected in cells treated with quercetin, 347 
suggesting the O-methylation by catechol O-methyl transferase (20). On the other hand, 348 
glucuronide or sulfate conjugates of these flavonols were not detected by HPLC-UV 349 
analyses (data not shown), indicating that these polyphenolic compounds are scarcely 350 
metabolized by conjugation reactions in this macrophage-like cell line, which has been 351 
reported to express β-glucuronidase to deconjugate flavonoid glucuronides (21). 352 
These data suggest that a certain degree of hydrophobicity of B ring moiety is 353 
required to interact with cells, and 3’-methoxylated structure is critical for inducing 354 
lysosomal activation. 355 
 356 
Isorhamnetin did not induce TFEB transactivation. 357 
We next attempted to investigate the molecular mechanism underlying the 358 
inducing effects of isorhamnetin on lysosomal activity. The time-course experiment 359 
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shown in Figure 1e had revealed that 24 h treatment with isorhamnetin was indispensable 360 
for exhibiting its activity, which strongly suggested the modulation of gene expressions 361 
might be involved in the mechanisms. Consistent with this hypothesis, co-treatment of 362 
actinomycin D, an inhibitor of RNA synthesis, completely canceled the lysosomal 363 
activation induced by isorhamnetin treatment [Fig. 4a]. Taken together, altering gene 364 
expressions is considered to be essential for the lysosomal activation by isorhamnetin. 365 
Considering the upstream mechanism of mRNA upregulation by isorhamnetin, 366 
we focused on TFEB, a transcriptional factor known as a master regulator of lysosomal 367 
biogenesis, whose activation has been reported to be controlled by mTORC1 signaling. 368 
To examine TFEB transactivation, we first observed its cellular localization in J774.1 369 
cells. Fluoroimaging cells expressing TFEB tagged by GFP revealed its diffused 370 
localization in cytoplasm. Unexpectedly, isorhamnetin treatment scarcely promote the 371 
nuclear translocation of GFP-TFEB while its nuclear translocation was obviously seen in 372 
Torin1-treated cells [Fig. 4b]. On the other hand, lysosomal gene expressions such as 373 
Atp6vod2, Ctsd and Lamp2a were confirmed to be upregulated by overexpression of a 374 
constitutively active mutant form of TFEB (TFEB-S3A/R4A) [Fig. 4c]. Importantly, 375 
mRNA expressions of these TFEB target genes were not induced by isorhamnetin 376 
treatment whereas Torin1 treatment significantly increased their expressions [Fig. 4d]. 377 
Furthermore, isorhamnetin scarcely altered phosphorylation level of 4E-BP1, an 378 
mTORC1 substrate, in contrast to Torin1 [Fig. 4e]. These data showed mTORC1-TFEB 379 
signaling is not modulated by isorhamnetin, and suggested the possibility that lysosomal 380 
functions in J774.1 macrophages could be regulated partly through the distinct 381 





Lysosome plays the pivotal role in the ultimate degradation on the catabolic 385 
processes through the endocytic and autophagic pathways. Whereas the effects of several 386 
dietary polyphenols on autophagy have been recently studied (12, 13, 14), there has been few 387 
reports paying attention to their effects on the lysosomal function. In this study, we 388 
performed the screening test on 56 kinds of compounds to find out dietary polyphenols 389 
which enhance the lysosomal proteolysis and identified isorhamnetin as an active 390 
compound. 391 
 Regarding the bioactivities of natural polyphenolic compounds, anti-oxidant and 392 
anti-inflammatory effects have been widely studied by both in vitro & in vivo experiments. 393 
Most of previous reports have shown that the anti-oxidant and anti-inflammatory activity 394 
of isorhamnetin was lower than that of quercetin, a 3’-O-demethylated derivative, due to 395 
lack of catechol structure (22, 23). Interestingly, our present study described that the effect 396 
of enhancing lysosomal activity was seen in only isorhamnetin rather than quercetin. This 397 
result strongly suggests that the molecular mechanism underlying the lysosomal 398 
activation by isorhamnetin is independent on its anti-oxidant and anti-inflammatory 399 
activities. Moreover, our study also indicated that the chemical structure of 3’-methoxy-400 
4’-hydroxy groups on B-ring moiety is critical for isorhamnetin activity. Considering 401 
these results, the lysosomal activation by isorhamnetin may require its physiological 402 
interaction to a specific intracellular molecule; that is to say, a certain key molecule may 403 
be interacted with isorhamnetin specifically and acting as its functional target in this 404 
cultured cell model. 405 
Isorhamnetin is a bioactive compound derived from herbal medicinal plants or 406 
vegetables such as potherb mustards, radish leaves and apples (without peels) (24). It has 407 
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been reported to possess multiple bioactivities like suppressive effects on arteriosclerosis 408 
in Apo-E knockout mice fed a high fat diet and adipocyte differentiation induced by 409 
rosiglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, in 3T3-L1 410 
cells (25, 26). Considering its low availability from dietary intake, it seems to be difficult to 411 
orally take sufficient amount of isorhamnetin, since its content in vegetables was shown 412 
to be much lower than quercetin, which is widely contained in vegetables. For instance, 413 
the total content of isorhamnetin glycosides in onion were reported to be approximately 414 
8-22 mg/100 g DW whereas that of quercetin glycosides were 171-294 mg/100 g DW (27). 415 
However, it is worth noting that isorhamnetin has also been identified as a metabolite of 416 
quercetin in mammalian serum, which is transformed through the methylation reaction at 417 
3’-hydoroxy group on B-ring by catechol-O-methyl-transferase mainly in the liver tissue. 418 
Indeed, serum concentration of isorhamnetin in mice has been reported to reach to 419 
approximately 2 µM after 6 weeks of feeding a diet supplemented with quercetin (2 mg/g) 420 
(28). These reports suggest the possibility of quercetin as a potent and practical activator 421 
of lysosome in in vivo models. 422 
This study investigated the molecular mechanisms underlying the lysosomal 423 
activation in isorhamnetin-treated J774.1 cells. Although data demonstrated that de novo 424 
gene expressions are closely involved in the mechanism, isorhamnetin treatment failed to 425 
promote TFEB nuclear translocation and the subsequent upregulation of lysosomal gene 426 
expressions such as Atp6v0d2, Ctsd and Lamp2a. Consistent with these results, 427 
isorhamnetin treatment also failed to repress the kinase activity of mTORC1, a negative 428 
regulator of TFEB transactivation. These data suggested that TFEB is not responsible for 429 
the mechanism of lysosomal activation by isorhamnetin in this cell line. Importantly, 430 
TFEB belongs to the MITF/TFE family of transcription factors that includes 431 
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microphthalmia-associated transcription factor (MITF), transcription factor binding to 432 
IGHM enhancer 3 (TFE3) and transcription factor EC (TFEC), and these 4 transcription 433 
factors have been reported to share the role in regulating similar series of lysosomal genes 434 
(29, 30, 31). However, it is predictable that 3 transcription factors other than TFEB are not 435 
participating in the mechanism of isorhamnetin, since the transactivation of these 436 
MITF/TFE families are found to be commonly controlled by mTORC1 signaling, 437 
similarly to that of TFEB. 438 
A previous report has described that treatment with genistein, one of the dietary 439 
isoflavone, upregulated lysosomal related gene expressions such as cathepsin F and 440 
mucolipin 1, and promoted lysosomal biogenesis through TFEB transactivation in HeLa 441 
cells (17). Although genistein has also been tested in our screening assay [Fig. 1c], it didn’t 442 
facilitate the lysosomal degradation of DQ-BSA in J774.1 cells. The higher concentration 443 
(50 µM) of genistein, compared with the previous report, also failed to activate lysosomal 444 
function in our assay [data not shown]. These observations strongly supported our 445 
prediction that unknown mechanisms independent on TFEB or MITF/TFE family are critical 446 
for the lysosomal regulation in J774.1 macrophages. 447 
In summary, our results indicate that isorhamnetin activates lysosomal function 448 
in J774.1, and the molecular mechanism is not related to mTORC1-TFEB signaling. It is 449 
likely that future studies on isorhamnetin will lead to the identification of the novel critical 450 
signaling pathway for the lysosomal regulation in macrophages. 451 
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 569 
Figure 1  Screening test revealed that isorhamnetin enhanced DQ-BSA degradation. 570 
J774.1 cells were treated with Torin1 (1 µM) for 24 h, then incubated with DQ-BSA (10 µg/mL) for 1 571 
h with/without bafilomycin A1 (100 nM) (a and b). Cells were treated with 56 kinds of polyphenolic 572 
compounds (10 µM each) for 24 h, then DQ-BSA was added to quantify the lysosomal proteolysis (c). 573 
Cells were treated with isorhamnetin at indicated concentrations for 24 h prior to DQ-BSA exposure 574 
(d). Cells were treated with isorhamnetin at 10 or 20 µM for different h as indicated prior to DQ-BSA 575 
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exposure (e). Green fluorescence inside cell was imaged and quantified using Operetta CLS™ and 576 
Harmony 4.5 (a-c) or Typhoon FLA9500 (d and e). Relative fluorescence intensities to DMSO control 577 
were graphed (b-e). Data represent means ± SEM of triplicate determinations (b, d and e). Different 578 
letters indicate significant differences by Tukey-Kramer test (p<0.05) (b). Statistical significance was 579 
analyzed using Dunnett's test (*p<0.05) (d and e). Abbreviations of polyphenolic compounds in figure 580 
1c are as follows: 3G; 3-glucoside, Q; quercetin, EGCG; epigallocatechin gallate, ECG; epicatechin 581 
gallate, EGC; epigallocatechin, EC; epicatechin, 7G; 7-glucosidice, Me; methyl. 582 
 583 
Figure 2  Isorhamnetin enhances the lysosomal number and proteolytic function. 584 
J774.1 cells were treated with isorhamnetin (10 µM) or Torin1 (1 µM) for 24 h, then incubated with 585 
lysotracker (0.5 µM) for 30 min (a) or Magic Red® (2 µL/well) for 10 min (c). Fluorescence 586 
intensities inside cells were imaged and quantified by using Operetta CLS™ and Harmony 4.5 (b and 587 
d). Degradation products of DQ-BSA by pronase digestion were detected by HPLC-fluorescence 588 
analysis (e). Cells were treated with isorhamnetin (10 µM) or Torin1 (1 µM) for 24 h, then incubated 589 
with DQ-BSA (10 µg/mL) for 1 h. Conditioned media were analyzed by HPLC-fluorescence analysis, 590 
and digested DQ-BSA was quantified (f and g). RAW264.7 cells were treated with isorhamnetin (10 591 
µM) or Torin1 (1 µM) for 24 h, then incubated with DQ-BSA (10 µg/mL) for 1 h. The fluorescence 592 
was quantified in the same way as Figure 1 (a) and (b), and relative fluorescence intensities to DMSO 593 
control were graphed (h). Data represent means ± SEM of triplicate determinations. Statistical 594 
significance was analyzed using the Dunnett's test (*p<0.05) (b, d, g and h). 595 
 596 
Figure 3  Structure-activity relationship of isorhamnetin for the lysosomal activation. 597 
Chemical structures of isorhamnetin and other 4 flavonols with varied B-ring moieties are shown (a). 598 
Cells were treated with indicated flavonols (10 µM each) for 24 h, then incubated with DQ-BSA (10 599 
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µg/mL) for 1 h. Intensities of cellular green fluorescence were quantified by Typhoon FLA9500 (b). 600 
Cells were treated with each flavonol (10 µM) for 1 or 24 h, and their amounts accumulated in cells 601 
were quantified by LC-MS/MS analysis (c). The relative amounts of flavonols after 24 h treatment to 602 
1 h treatment were shown (d). Data represent means ± SEM of triplicate determinations (b-d). 603 
Different letters indicate significant differences by Tukey-Kramer test (p<0.05) (b and d). Statistical 604 
significance was assessed using unpaired t-test (*p<0.05) (c). 605 
 606 
Figure 4  mTORC1-TFEB signaling is not activated by isorhamnetin treatment. 607 
Cells were treated with isorhamnetin (10 µM) with/without actinomycin D (5 µM) for 24 h. After DQ-608 
BSA exposure, cellular fluorescence intensities were quantified by Typhoon FLA9500 (a). GFP-TFEB 609 
expressing cells were treated with isorhamnetin (10 µM) or Torin1 (1 µM) for 1 h, then nuclei were 610 
stained with Hoechst33342. Cellular fluorescence was imaged by using Operetta CLS™ (b). Relative 611 
mRNA expressions of indicated lysosomal genes in cells overexpressing constitutively activated 612 
TFEB (TFEB-S3A/R4A) (c). Relative mRNA expressions of TFEB target genes after the incubation 613 
with isorhamnetin (10 µM) for 8 h (d). Phosphorylated forms of 4E-BP1 in cells treated with 614 
isorhamnetin (10 µM) or Torin1 (1 µM) for 1 h (e). Data represent means ± SEM of triplicate 615 
determinations (a, c and d). Different letters indicate significant differences by Tukey-Kramer test 616 
(p<0.05) (a). Statistical significance was analyzed using Dunnett's test (*p<0.05) 617 
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